6 Recruiting Stargardt Disease Phase 2 Clinical Trials
Active phase 2 studies for stargardt disease enrolling across the USA. Verify eligibility and contact site coordinators.
All Stargardt Disease studiesPhase 2 Studies for Stargardt Disease
🔵 Active, Not Recruiting Phase2
Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)
📍 Alkeus Site — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
📍 Associated Retina Consultants — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
📍 RayTx Clinical Site — Bakersfield, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
📍 University of San Francisco — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
📍 Associated Retina Consultants — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
📍 UCHealth Sue Anschutz-Rodgers Eye Center, — Aurora, Colorado
View Study & Checklist ➔